FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
08/01/2026
Voltar para busca
Dado oficial do USPTO
AFFIBODY
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
38
Atualização mais recente
03/04/2026
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
1, 5, 10, 42, 44
Data de depósito
31/03/2023
Data de registro
27/05/2025
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
27/05/2025
Última transação
03/04/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
3
Tipo de titular
99
Localização do titular
SE
Examinador
SWIFT, GILBERT M
Unidade examinadora
L90
Localização atual
FILE REPOSITORY (FRANCONIA)
Descrição da marca
The mark consists of the black wording, "AFFIBODY" at right; the blue design of three solid circles over a solid, curved band appears at left; the color white represents background, outlining, shading and/or transparent areas and is not part of the mark.
Titulares e representantes
Titulares
Affibody AB
Representantes
Jessica S. Sachs Harness, Dickey & Pierce, P.L.C.
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 10Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Chemical substances and materials for industrialscientific and laboratory use other than for medical or veterinary purposes; chemical reagents other than for medical or veterinary purposesbiochemical preparations for scientific purposes; biochemical substances for scientific purposes; chemical substances for use in the production of drugspharmaceuticals and antibodies; reagents for scientificlaboratoryanalysisresearchmedical researchtestinginspectiondetecting or verification use other than for medical or veterinary purposes; reagents for use in the development of antibodies other than for medical or veterinary purposes; reagents for use in scientific apparatus for chemical or biological analysis other than for medical or veterinary purposes; antibodies and antibodies-based chemicalsexcept for medical or veterinary use
Classe 5
Medical and veterinary substancespreparations and articlesMedical diagnostic reagents and assays for testing of bodily fluidsClinical diagnostic reagents for medical useDiagnostic biomarker reagents for medical purposesDiagnostic reagents and agents for medical diagnostic useDiagnostic reagents for clinical laboratory useReagents for use in medical genetic testingRadiopharmaceutical imaging and detection agents for diagnosing and monitoring cancercontrast media for use with imaging medical equipment; pharmaceutical preparations and substancesbiochemical preparationsbiological preparationsantibodies and antibodies-based pharmaceutical preparations for the treatment of neoplasmscancer diseasesinflammatory eyeskinmuscle and joint diseases and disordersdiseases and disorders of the immune systemautoimmune diseases and disorderslocal and systemic bacterial infectionsviral infectionsfungal infectionscentral nervous system (CNS) diseasescirculatory systemrespiratory systemrespiratory diseases and disorderscardiovascular diseasesrenal diseasesliver diseasesskin diseasesdiseases of the digestive systemgastro-intestinal diseaseseye diseases and conditionsdiseases of the musculoskeletal system or connective tissue; pharmaceutical preparations and substancesbiochemical preparationsbiological preparationsantibodies and antibodies-based pharmaceutical preparations for the treatment of diseases and disorders of the peripheral nervous systemnamely cranial and spinal neuropathiesautonomic neuropathiessensorimotor neuropathies and plexopathiesdiseases of the blood or blood forming organs; pharmaceutical preparationsbiochemical preparationsbiological preparationsantibodies and antibodies-based pharmaceutical preparations for the treatment of disorders of the lymphatic systems namely LymphangitisLymphocytosisMesenteric lymphadenitis; pharmaceutical preparationsbiochemical preparationsbiological preparationsantibodies and antibodies-based pharmaceutical preparations for the treatment of metabolic diseases namely obesitydiabetesmetabolic syndromeinborn errors of metabolismhypoglycaemiagoutosteoarthritismuscular dystrophyanemia; pharmaceutical preparationsbiochemical preparationsbiological preparationsantibodies and antibodies-based pharmaceutical preparations for the treatment of diseases of the endocrine systemnamely glucose homeostasis disordersthyroid disorderscalcium homeostasis disorders and metabolic bone diseasepituitary gland disorderssex hormone disorders and tumours of the endocrine glands; pharmaceutical preparationsbiochemical preparationsbiological preparationsantibodies and antibodies-based pharmaceutical preparations for use in ophthalmology; pharmaceutical preparationsbiochemical preparationsbiological preparationsantibodies and antibodies-based pharmaceutical preparations for the treatment of diseases of the genitourinary systemnamely prostatereproductive and urological diseases and disorders; diagnostic preparations and materials for medical purposes; medical therapeutic agents for regulation of biological functionsprotein inhibition or activationweight control and appetite suppression; reagents for medicalsurgicalveterinary and dental use; biochemical biomarkers for medical use; diagnostic biomarker reagents for medical purposes; sanitary preparations for medical purposes
Classe 10
Medical and veterinary apparatus and instrumentsmedical apparatus and instruments for use in surgerychromatography media in the nature of liquid chromatography apparatus for medical use in medical research; diagnosticexaminationmonitoring equipment namelymedical apparatus and instruments for diagnostic radiopharmaceutical use; screening apparatus and instruments for medical purposesultrasonic medical diagnostic apparatus; separation instruments for medical usetubing and valve assembly set and electromechanical fluidic instrumentother similar or related deviceswhich process human whole blood for the purpose of separating human blood components for use in blood transfusions and washing human red blood cells with clinical medical reagents for use in blood transfusions chromatography columns for use in affinity separationchromatography media for use in affinity separation; gas chromatographic instruments for medical use; diagnostic imaging apparatus for medical use; medication fluid injectors
Classe 42
Scientific researchtechnological researchproduct development and design in the field of biotechnics and diagnostics; medical and pharmacological research services for medical purposes in the field of biotechnics and diagnostics; medicalpharmaceutical and biotechnological laboratory research services for medical purposes in the field of biotechnics and diagnostics; scientific investigations for medical purposes; medical and scientific researchconducting clinical trials for others; providing scientific information about the results of clinical trials for pharmaceutical products; scientific advisory services relating to diagnostic preparations; biochemical analysis and research for medical purposes in the field of biotechnics and diagnostics; drug discovery services; pharmaceutical products development and evaluation
Classe 44
Human healthcare services; medical services; providing medical information; physical examination; medical diagnostic testingmonitoring and reporting services; optical medical imaging for medical diagnostic use; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical testing for diagnostic or treatment purposes
Publicações
Histórico de despachos e eventos da marca no USPTO.
38 publicações encontradas
FICS
FINAL DISPOSITION NOTICE SENT TO IB
22/12/2025
FIMP
FINAL DISPOSITION PROCESSED
22/12/2025
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
27/08/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
27/05/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
27/05/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/04/2025
PUBO
PUBLISHED FOR OPPOSITION
08/04/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/04/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
13/03/2025
XAEC
EXAMINER'S AMENDMENT ENTERED
13/03/2025
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
13/03/2025
GNEA
EXAMINERS AMENDMENT E-MAILED
13/03/2025
CNEA
EXAMINERS AMENDMENT -WRITTEN
13/03/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/03/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/03/2025
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
05/03/2025
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
04/01/2025
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
18/12/2024
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
18/12/2024
GNS1
NOTIFICATION OF SUBSEQUENT FINAL EMAILED
16/09/2024
GNSF
SUBSEQUENT FINAL EMAILED
16/09/2024
CFRC
SUBSEQUENT FINAL REFUSAL WRITTEN
16/09/2024
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
11/09/2024
GNFR
FINAL REFUSAL E-MAILED
11/09/2024
CNFR
FINAL REFUSAL WRITTEN
11/09/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/07/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/07/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/07/2024
RFNT
REFUSAL PROCESSED BY IB
31/01/2024
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
11/01/2024
RFRR
REFUSAL PROCESSED BY MPU
11/01/2024
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
29/12/2023
CNRT
NON-FINAL ACTION WRITTEN
28/12/2023
DOCK
ASSIGNED TO EXAMINER
27/12/2023
MAFR
APPLICATION FILING RECEIPT MAILED
25/07/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
21/07/2023
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
20/07/2023
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace AFFIBODY ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.